iShares Biotechnology ETF
NASDAQ · us_market
No AI insight generated yet for this ticker.
The fund generally will invest at least 80% of its assets in the component securities of its underlying index and may invest up to 20% of its assets in certain futures, options and swap contracts, cash and cash equivalents. It is non-diversified.
| Fund | Style | Shares | Value | % of Port | Change vs. last quarter | Period |
|---|---|---|---|---|---|---|
| Bridgewater | macro | 1.77M | $217.27M | 0.97% | Trimmed-14.8% | 2026-03-31 |
| DEShaw | quant | 682.0K | $83.89M | 0.05% | New | 2026-03-31 |
| TwoSigma | quant | 490.1K | $60.29M | 0.05% | Added+178.8% | 2026-03-31 |
| FidelityFMR | fundamental | 353.9K | $43.53M | 0.00% | Unchanged | 2026-03-31 |
| RenTech | quant | 231.3K | $28.46M | 0.04% | New | 2026-03-31 |
| TRowePrice | fundamental | 10.1K | $1.24K | 0.00% | Added+2.8% | 2026-03-31 |